Logo image of ALL

ALLSTATE CORP (ALL) Stock Fundamental Analysis

NYSE:ALL - New York Stock Exchange, Inc. - US0200021014 - Common Stock - Currency: USD

195.06  +6.63 (+3.52%)

Premarket: 195.2 +0.14 (+0.07%)

Fundamental Rating

4

Taking everything into account, ALL scores 4 out of 10 in our fundamental rating. ALL was compared to 144 industry peers in the Insurance industry. ALL has a bad profitability rating. Also its financial health evaluation is rather negative. ALL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALL was profitable.
ALL had a positive operating cash flow in the past year.
In multiple years ALL reported negative net income over the last 5 years.
Of the past 5 years ALL 4 years had a positive operating cash flow.
ALL Yearly Net Income VS EBIT VS OCF VS FCFALL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

The Return On Assets of ALL (3.61%) is better than 66.20% of its industry peers.
ALL has a Return On Equity of 19.69%. This is amongst the best in the industry. ALL outperforms 81.69% of its industry peers.
Industry RankSector Rank
ROA 3.61%
ROE 19.69%
ROIC N/A
ROA(3y)0.78%
ROA(5y)1.63%
ROE(3y)3.78%
ROE(5y)7.06%
ROIC(3y)N/A
ROIC(5y)N/A
ALL Yearly ROA, ROE, ROICALL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15 20

1.3 Margins

With a Profit Margin value of 6.58%, ALL perfoms like the industry average, outperforming 47.89% of the companies in the same industry.
ALL's Profit Margin has declined in the last couple of years.
ALL's Operating Margin of 9.01% is in line compared to the rest of the industry. ALL outperforms 47.18% of its industry peers.
In the last couple of years the Operating Margin of ALL has declined.
Industry RankSector Rank
OM 9.01%
PM (TTM) 6.58%
GM N/A
OM growth 3Y-11.15%
OM growth 5Y-7.38%
PM growth 3Y34.22%
PM growth 5Y-8.82%
GM growth 3YN/A
GM growth 5YN/A
ALL Yearly Profit, Operating, Gross MarginsALL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

ALL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALL has more shares outstanding
ALL has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ALL has been reduced compared to a year ago.
ALL Yearly Shares OutstandingALL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
ALL Yearly Total Debt VS Total AssetsALL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of ALL is 0.98, which is an excellent value as it means it would take ALL, only 0.98 years of fcf income to pay off all of its debts.
ALL has a better Debt to FCF ratio (0.98) than 67.61% of its industry peers.
ALL has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALL (0.39) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.98
Altman-Z N/A
ROIC/WACCN/A
WACC8.17%
ALL Yearly LT Debt VS Equity VS FCFALL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ALL Yearly Current Assets VS Current LiabilitesALL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1913.19% over the past year.
The Earnings Per Share has been growing by 11.88% on average over the past years. This is quite good.
Looking at the last year, ALL shows a quite strong growth in Revenue. The Revenue has grown by 12.28% in the last year.
Measured over the past years, ALL shows a quite strong growth in Revenue. The Revenue has been growing by 9.06% on average per year.
EPS 1Y (TTM)1913.19%
EPS 3Y11.04%
EPS 5Y11.88%
EPS Q2Q%31.79%
Revenue 1Y (TTM)12.28%
Revenue growth 3Y8.21%
Revenue growth 5Y9.06%
Sales Q2Q%8.84%

3.2 Future

ALL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.86% yearly.
Based on estimates for the next years, ALL will show a small growth in Revenue. The Revenue will grow by 5.05% on average per year.
EPS Next Y-3.25%
EPS Next 2Y7.95%
EPS Next 3Y7.86%
EPS Next 5YN/A
Revenue Next Year6.81%
Revenue Next 2Y7.37%
Revenue Next 3Y11.03%
Revenue Next 5Y5.05%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALL Yearly Revenue VS EstimatesALL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
ALL Yearly EPS VS EstimatesALL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15 20

5

4. Valuation

4.1 Price/Earnings Ratio

ALL is valuated reasonably with a Price/Earnings ratio of 10.65.
63.38% of the companies in the same industry are more expensive than ALL, based on the Price/Earnings ratio.
ALL is valuated cheaply when we compare the Price/Earnings ratio to 29.01, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 11.01, the valuation of ALL can be described as reasonable.
ALL's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.40. ALL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.65
Fwd PE 11.01
ALL Price Earnings VS Forward Price EarningsALL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ALL's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ALL is valued a bit cheaper than the industry average as 63.38% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.29
EV/EBITDA 9.52
ALL Per share dataALL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2Y7.95%
EPS Next 3Y7.86%

6

5. Dividend

5.1 Amount

ALL has a Yearly Dividend Yield of 1.95%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.16, ALL has a dividend in line with its industry peers.
ALL's Dividend Yield is comparable with the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 1.95%

5.2 History

The dividend of ALL is nicely growing with an annual growth rate of 12.54%!
ALL has paid a dividend for at least 10 years, which is a reliable track record.
ALL has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)12.54%
Div Incr Years14
Div Non Decr Years15
ALL Yearly Dividends per shareALL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

26.17% of the earnings are spent on dividend by ALL. This is a low number and sustainable payout ratio.
The dividend of ALL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP26.17%
EPS Next 2Y7.95%
EPS Next 3Y7.86%
ALL Yearly Income VS Free CF VS DividendALL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B
ALL Dividend Payout.ALL Dividend Payout, showing the Payout Ratio.ALL Dividend Payout.PayoutRetained Earnings

ALLSTATE CORP

NYSE:ALL (2/27/2025, 8:04:00 PM)

Premarket: 195.2 +0.14 (+0.07%)

195.06

+6.63 (+3.52%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners79.83%
Inst Owner Change5.7%
Ins Owners0.53%
Ins Owner Change0.97%
Market Cap51.69B
Analysts78.4
Price Target234.41 (20.17%)
Short Float %0.97%
Short Ratio1.55
Dividend
Industry RankSector Rank
Dividend Yield 1.95%
Yearly Dividend3.93
Dividend Growth(5Y)12.54%
DP26.17%
Div Incr Years14
Div Non Decr Years15
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)198.67%
Min EPS beat(2)64.3%
Max EPS beat(2)333.04%
EPS beat(4)4
Avg EPS beat(4)117.63%
Min EPS beat(4)28.89%
Max EPS beat(4)333.04%
EPS beat(8)7
Avg EPS beat(8)68.67%
EPS beat(12)8
Avg EPS beat(12)47.92%
EPS beat(16)11
Avg EPS beat(16)40.32%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-2.51%
Max Revenue beat(2)-0.07%
Revenue beat(4)1
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)1.38%
Revenue beat(8)2
Avg Revenue beat(8)1.6%
Revenue beat(12)6
Avg Revenue beat(12)6.49%
Revenue beat(16)10
Avg Revenue beat(16)10.55%
PT rev (1m)0.57%
PT rev (3m)4.82%
EPS NQ rev (1m)11.17%
EPS NQ rev (3m)13.32%
EPS NY rev (1m)-7.76%
EPS NY rev (3m)-8.04%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 10.65
Fwd PE 11.01
P/S 0.83
P/FCF 6.29
P/OCF 6.12
P/B 2.48
P/tB 2.93
EV/EBITDA 9.52
EPS(TTM)18.32
EY9.39%
EPS(NY)17.72
Fwd EY9.09%
FCF(TTM)31.02
FCFY15.9%
OCF(TTM)31.89
OCFY16.35%
SpS235.59
BVpS78.78
TBVpS66.68
PEG (NY)N/A
PEG (5Y)0.9
Profitability
Industry RankSector Rank
ROA 3.61%
ROE 19.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.01%
PM (TTM) 6.58%
GM N/A
FCFM 13.17%
ROA(3y)0.78%
ROA(5y)1.63%
ROE(3y)3.78%
ROE(5y)7.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-11.15%
OM growth 5Y-7.38%
PM growth 3Y34.22%
PM growth 5Y-8.82%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 0.98
Debt/EBITDA 1.31
Cap/Depr 40.6%
Cap/Sales 0.37%
Interest Coverage 250
Cash Conversion 136.46%
Profit Quality 199.95%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score8
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1913.19%
EPS 3Y11.04%
EPS 5Y11.88%
EPS Q2Q%31.79%
EPS Next Y-3.25%
EPS Next 2Y7.95%
EPS Next 3Y7.86%
EPS Next 5YN/A
Revenue 1Y (TTM)12.28%
Revenue growth 3Y8.21%
Revenue growth 5Y9.06%
Sales Q2Q%8.84%
Revenue Next Year6.81%
Revenue Next 2Y7.37%
Revenue Next 3Y11.03%
Revenue Next 5Y5.05%
EBIT growth 1Y371.17%
EBIT growth 3Y-3.85%
EBIT growth 5Y1.02%
EBIT Next Year19.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y121.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y112.71%
OCF growth 3YN/A
OCF growth 5YN/A